AbbVie Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (195)

Latest Posts

About This Stock More About This Stock
Reap Monthly Income With This Combination Of 3 Stocks
Article By: Zacks Investment Research
Thursday, March 9, 2023 6:00 PM EDT
While the majority of stocks pay quarterly dividends, investors can still construct a portfolio that allows them to get paid monthly.
In this article: KO, XOM, ABBV
Read
Recent Stock Purchase/Sale February 2023
Article By: Keith Park
Sunday, February 26, 2023 6:46 AM EDT
I have been busy buying up some stock this month and was happy to put some fresh and recycled capital to work to try and recoup some of my lost dividend income courtesy of the numerous cuts bestowed upon my portfolio in recent years (thanks VF Corp).
In this article: VFC, ABBV, HLN, GEHC
Read
3 Stocks For Rising Passive Income
Article By: SureDividend
Wednesday, January 4, 2023 8:42 AM EDT
The prospects of three stocks that are ideal for rising passive income.
In this article: ENB, PEP, ABBV
Read
12 Forever Stocks For Generational Rising Passive Income
Article By: SureDividend
Saturday, December 31, 2022 6:53 PM EDT
A look at 12 “forever” stocks coming from various industries, including technology, healthcare, and consumer goods, with solid track records of growth and stability.
In this article: ENB, MDU, O, PEP, CINF, MATW, QCOM, ABBV
Read
Tuesday Talk: Where Is Santa?
Article By: TalkMarkets DailyTalk
Tuesday, December 20, 2022 5:21 AM EDT
Monday continued the downtrend for the major indices on Wall Street which concluded a second week of losses on Friday. As for an annual Santa rally, that seems nowhere to be found.
In this article: T, WBD, LLY, MRK, UNH, REGN, GILD, VRTX, IWM, XBI, ABBV
Read

Latest Tweets for $ABBV

No tweets yet!

PARTNER HEADLINES

$ABBV

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/11/2020 4:12:58 AM

Just a hunch. The healthcare industry is highly regulated and Dems generally favor more regulation, making it more difficult for drugmakers to secure the necessary regulatory approvals to market new products. Regulatory changes could drastically alter a healthcare stock’s growth prospects, for instance. But I reckon I'll not sell $ABBV after holding during all the long downward spiral.

5 Leading Healthcare Stocks Surging On Pent-up Demand
Craig Newman 11/10/2020 2:44:59 AM

Seems health stocks should do well but a #Biden presidency will not favor this sector. $ABBV $PFE

Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

AbbVie: Is This Biopharma Giant’s 6% Yield Safe?
Beating Buffett 7/11/2019 1:00:14 PM

How much debt does $ABBV have?

AbbVie Has It All: Growth, Dividend Growth And Compelling Valuation
Dan Richards 6/25/2019 11:19:59 PM

$ABBV certainly sounds like a great buy.

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 6 of 6 comments